Last reviewed · How we verify
NCT06712238
Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients
NA trial testing NB-UVB in Psoriatic Conditions in 48 participants. Currently enrolling.
1 June 2025
Quick facts
| Lead sponsor | Aswan University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 10 June 2024 |
| Primary completion | 1 June 2025 |
| Estimated completion | 10 June 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- NB-UVB — full drug profile →
Conditions studied
- Psoriatic Conditions — all drugs for Psoriatic Conditions →
Sponsor
Aswan University
Who can join
Adults 15 to 65, any sex, with Psoriatic Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Psoriasis is a common chronic, immune-mediated, skin disease with a significantly negative impact on patients' quality of life. It is one of papulosquamous diseases defined by erythematous plaques with silvery scales. The interplay among cytokines released by dendritic, Th1, Th2, and Th17 cells leads to the clinical manifestations seen in psoriasis. Although discovering novel biomarkers for psoriasis is challenging step., it may play an essential role in diagnosis, severity assessment and prediction of treatment outcome and prognosis of the disease
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Exploring the role of gelsolin and high-density lipoproteins in autoimmune diseases: spotlight on rheumatoid arthritis and systemic lupus erythematosus.
Pérez-Ocampo J, Hernandez JC. · · 2026 · PMID 41710123 · DOI 10.1093/oxfimm/iqag002
Verify or expand the search:
- PubMed search for NCT06712238
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NB-UVB
Trials testing the same drug.
- NCT06593197 — Efficacy and Safety of Apremilast in Combination with NBUVB and NBUVB Alone in Vitiligo Patients · Phase 4 · enrolling by invitation
- NCT04811326 — Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation · Phase 4 · unknown
- NCT05647187 — Effect Narrow-Band UVB Radiations · NA · completed
- NCT04071106 — Turmeric Based Therapy in the Treatment of Psoriasis: A Clinical Trial · Phase 2, PHASE3 · unknown
- NCT03526705 — The Effect of NB-UVB on Interleukin-36 Levels in Psoriasis · NA · unknown
Other recruiting trials for Psoriatic Conditions
Currently open trials in the same condition.
- NCT05621369 — Psorcast Mobile Study · recruiting
Other Aswan University trials
Trials by the same sponsor.
- NCT07232238 — TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients · active not recruiting
- NCT07140640 — Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Str · Phase 4 · not yet recruiting
- NCT07466719 — Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Un · NA · recruiting
- NCT07320872 — Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris · recruiting
- NCT07109947 — Use of Aromatase Inhibitor Before Misoprostol in Medical Termination of Miscarriage · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06712238 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aswan University
- Last refreshed: 2 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06712238.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing